Chronic Disease
Featured Topics
Lead story
Other featured articles
-
Material–Psychosocial–Behavioral Aspects of Financial Hardship: A Conceptual Model for Cancer Prevention
RCMAR Scientist Reginald Tucker-Seeley presents a model to consistently measure financial hardship to better inform cancer prevention research identify connections between socioeconomic circumstances and cancer risk-related behaviors and cancer screening among older adults.
Posted in -
Briefing: Return on Investment of Early Intervention in Mental Health Care
Join us for a briefing on what California can learn about investing in mental health prevention and early intervention and mitigating burdensome lifetime costs of untreated mental illness.
Posted in -
Economic Dimensions of Personalized and Precision Medicine
The book explores recent empirical applications of personalized and precision medicine, as well as the intersection of the scientific, clinical, and economic factors affecting the development of PPM.
-
To Help People with Mental Illness, Keep Them in School
In the struggle to help people with mental illness cope with their affliction, a powerful long term tool has been overlooked: school. Seth Seabury and Thomas Insel write on the importance of education in expanding opportunities for patients with serious mental illness.
Posted in
About this section
Chronic diseases are among the most preventable and costliest conditions, consuming the overwhelming majority of Medicare resources. The Schaeffer Center assembles leading minds from across disciplines to address this challenge, striving to simplify labyrinthine systems of care and promote healthier outcomes.
Our Experts On Chronic Disease
Our Work In Chronic Disease
-
Researchers Link Educational Attainment to Reduced Burden of Serious Mental Illness
A new USC Schaeffer Center study shows the return on investing in improving educational attainment for those diagnosed with serious mental illness by age twenty-five, projecting positive impacts on health and economic outcomes.
Categorized in -
A New Way to Pay for Innovative Drugs, Provide Universal Access and Not Break the Bank
Neeraj Sood penned an analysis of Louisiana’s new path to curing hepatitis C among its Medicaid and prison populations. It is the first state to implement a solution proposed by Sood in a National Academies of Sciences consensus report and in a leading medical journal.
Categorized in -
NIH Awards USC School of Pharmacy, Price School of Public Policy 5-Year Grant to Support Minority Aging Research in Schaeffer Center
The $2.7 million award funds scholars pursuing research in health disparities in aging with an emphasis on Alzheimer’s disease.
Categorized in -
Mortality Risk, Insurance, and the Value of Life
People with shorter life expectancies place more value on increases in survival than people who anticipate longer life spans.
Categorized in -
The Association of Multiple Anti-Hypertensive Medication Classes with Alzheimer’s Disease Incidence Across Sex, Race, and Ethnicity
The researchers find hypertension management treatments that include RAS-acting ARBs may, in addition to lowering blood pressure, reduce AD risk, particularly for white and black women and white men.
-
Some Blood Pressure Medications May Reduce Risk of Alzheimer’s, But Not For All Populations
Certain antihypertensive medications may prevent the onset of the disease, but only among black and white women and white men.